Today: May 25, 2018, 12:27 pm
  
Business

Spark Therapeutics to Host Conference Call on Tuesday, Feb. 20 at 8:30 a.m. ET to Discuss 2017 Results and Recent Business Highlights

PR-Inside.com: 2018-02-13 13:33:01

Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on Tuesday, Feb. 20, 2018, at 8:30 a.m. ET to discuss corporate and financial results for the year that ended Dec. 31, 2017 and recent business highlights.

The call can be accessed by dialing (855) 851-4526 (domestic) or (720) 634-2901 (international), and entering passcode 9596288. To access a live audio webcast, please visit the "Investors" section at www.sparktx.com.

A replay of the call will be available for one week following the call and can be accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international), and entering passcode 9596288, or by visiting the "Investors" section at www.sparktx.com.

About Spark Therapeutics
At Spark Therapeutics, a fully integrated company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia and neurodegenerative diseases. We have successfully applied our technology in the first FDA-approved gene therapy in the U.S. for a genetic disease, and currently have three programs in clinical trials, including product candidates that have shown promising early results in patients with hemophilia. At Spark, we see the path to a world where no life is limited by genetic disease. For more information, visit www.sparktx.com, and follow us on Twitter and LinkedIn.

Investor Contact:
Ryan Asay
Ryan.asay@sparktx.com
(215) 239-6424
Media Contact:
Monique da Silva
Monique.dasilva@sparktx.com
(215) 282-7470



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Spark Therapeutics, Inc. via Globenewswire




# 499 Words
Related Articles
More From The Author
New Fair Go Pokie Packs a Punch
Australia’s favourite online casino, Fair Go Casino : Players will need to be Kung Fu fighting in this 5x3 reel [..]
Drooms to Focus on International Expansion and [..]
With the appointment of Steffen Schaack as Senior Vice President Real Estate, Drooms : Drooms plans to tap into additional [..]
Sampo plc: Disclosure Under Chapter 9 Section [..]
SAMPO PLC        STOCK EXCHANGE RELEASE       13 February 2018 at 1:55 pm Disclosure Under Chapter 9 Section 5 [..]
Nets A/S: Notice of compulsory acquisition of [..]
Company announcement No. 10/2018   Notice of compulsory acquisition of remaining shares in Nets A/S With reference to company announcement [..]
The Works Implements RichRelevance AI-Powered Personalised Online [..]
RichRelevance : Previously, The Works team lacked visibility into their site search performance due to employing a black-box solution. [..]
 
More From Business
G2H2 Capital Makes a Purchase on the [..]
HONG KONG, May 24, 2018 - (ACN Newswire) - G2H2 Capital ("G2H2") signed an agreement with AnApp Blockchain Technologies Limited [..]
Oppenheimer Europe CEO Max Lami On Course [..]
Oppenheimer Europe CEO Max Lami On Course With M&A Business Expansion Plan, Four Years On Nearly four years have passed [..]
AnApp announces the birth of an innovative [..]
HONG KONG, May 21, 2018 - (ACN Newswire) - AnApp Blockchain Technologies Limited ("AnApp") announces the development of [..]
HKTDC Entrepreneur Day 2018 Opens
Most International and Tech-focused Edition Ever HONG KONG, May 17, 2018 - (ACN Newswire) - A record 276 exhibitors are [..]
Stripe and JCB Sign MOU for Global [..]
Enabling JCB brand payment at merchants around the world using the Stripe payment platform San Francisco and Tokyo, May 17, [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.